In a study on genomic instability in cancer published in Cell in 2012, Nijhawan et al. found a partial deletion of PSMC2, which makes cancer cells highly dependent on the remaining PSMC2, suggesting that PSMC2 could be a potential target for cancer treatment [14]. The gene discussed is PSMC2; the disease is cancer.